CK Life Sciences Int'l., (Holdings) Inc.

SEHK:775 Voorraadrapport

Marktkapitalisatie: HK$4.5b

CK Life Sciences Int'l. (Holdings) Beheer

Beheer criteriumcontroles 2/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Lance Richard Lee Yuen

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOless than a year
Eigendom CEOn/a
Management gemiddelde ambtstermijn14.2yrs
Gemiddelde ambtstermijn bestuur6yrs

Recente managementupdates

Recent updates

CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Share Price Boosted 34% But Its Business Prospects Need A Lift Too

Oct 04
CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Share Price Boosted 34% But Its Business Prospects Need A Lift Too

There's No Escaping CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Muted Revenues Despite A 32% Share Price Rise

May 03
There's No Escaping CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Muted Revenues Despite A 32% Share Price Rise

CK Life Sciences Int'l. (Holdings)'s (HKG:775) Anemic Earnings Might Be Worse Than You Think

Apr 25
CK Life Sciences Int'l. (Holdings)'s (HKG:775) Anemic Earnings Might Be Worse Than You Think

CK Life Sciences Int'l. (Holdings) (HKG:775) Use Of Debt Could Be Considered Risky

Mar 26
CK Life Sciences Int'l. (Holdings) (HKG:775) Use Of Debt Could Be Considered Risky

Here's Why CK Life Sciences Int'l. (Holdings) (HKG:775) Can Manage Its Debt Responsibly

Sep 27
Here's Why CK Life Sciences Int'l. (Holdings) (HKG:775) Can Manage Its Debt Responsibly

Does CK Life Sciences Int'l. (Holdings) (HKG:775) Have A Healthy Balance Sheet?

Sep 16
Does CK Life Sciences Int'l. (Holdings) (HKG:775) Have A Healthy Balance Sheet?

Estimating The Intrinsic Value Of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775)

Aug 21
Estimating The Intrinsic Value Of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775)

These 4 Measures Indicate That CK Life Sciences Int'l. (Holdings) (HKG:775) Is Using Debt Extensively

Apr 14
These 4 Measures Indicate That CK Life Sciences Int'l. (Holdings) (HKG:775) Is Using Debt Extensively

CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Delivered A Weaker ROE Than Its Industry

Mar 18
CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Delivered A Weaker ROE Than Its Industry

If You Had Bought CK Life Sciences Int'l. (Holdings) (HKG:775) Shares Five Years Ago You'd Have Earned 45% Returns

Feb 01
If You Had Bought CK Life Sciences Int'l. (Holdings) (HKG:775) Shares Five Years Ago You'd Have Earned 45% Returns

What Kind Of Shareholders Hold The Majority In CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Shares?

Jan 04
What Kind Of Shareholders Hold The Majority In CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Shares?

CK Life Sciences Int'l. (Holdings) (HKG:775) Has A Somewhat Strained Balance Sheet

Dec 09
CK Life Sciences Int'l. (Holdings) (HKG:775) Has A Somewhat Strained Balance Sheet

We Wouldn't Rely On CK Life Sciences Int'l. (Holdings)'s (HKG:775) Statutory Earnings As A Guide

Nov 18
We Wouldn't Rely On CK Life Sciences Int'l. (Holdings)'s (HKG:775) Statutory Earnings As A Guide

CEO

Lance Richard Lee Yuen (59 yo)

less than a year

Tenure

Mr. Lance Richard Lee Yuen is Executive Director, Vice President & Chief Executive Officer of CK Life Sciences Int'l. (Holdings) Inc. from September 20, 2024. Mr. Yuen joined the Group in September 2024.M...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Tzar Kuoi Li
Executive Chairman 22.6yrsHK$125.00k0.023%
HK$ 1.1m
Hing Lam Kam
President & Executive Director22.4yrsHK$2.58m0.065%
HK$ 2.9m
Edmond Tak Chuen IP
Senior VPno dataHK$1.60m0.023%
HK$ 1.1m
Kean Meng Toh
VP, Chief Scientific Officer & Executive Director6yrsHK$6.13mgeen gegevens
Lance Richard Lee Yuen
VP, CEO & Executive Directorless than a yeargeen gegevensgeen gegevens
Wun Lam Wong
Chief Financial Officerno datageen gegevensgeen gegevens
Pak To Wu
Chief Operating Officer of Global Operationsno datageen gegevensgeen gegevens
Yau Wong
Senior Manager of Human Resources & Administrationno datageen gegevensgeen gegevens
Ching Sze Chiu
General Counselno datageen gegevensgeen gegevens
Sze Ho
Vice President of Corporate Developmentno datageen gegevensgeen gegevens
Wai Che Tong Barnes
Chief Corporate Affairs Officerno datageen gegevensgeen gegevens
Eirene Yeung
Company Secretary22.8yrsgeen gegevensgeen gegevens

14.2yrs

Gemiddelde duur

59.5yo

Gemiddelde leeftijd

Ervaren management: 775's management team is seasoned and experienced (14.2 years average tenure).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Tzar Kuoi Li
Executive Chairman 22.6yrsHK$125.00k0.023%
HK$ 1.1m
Hing Lam Kam
President & Executive Directorno dataHK$2.58m0.065%
HK$ 2.9m
Edmond Tak Chuen IP
Senior VPno dataHK$1.60m0.023%
HK$ 1.1m
Kean Meng Toh
VP, Chief Scientific Officer & Executive Director6yrsHK$6.13mgeen gegevens
Lance Richard Lee Yuen
VP, CEO & Executive Directorless than a yeargeen gegevensgeen gegevens
Eva Kwok
Independent Non-Executive Director22.4yrsHK$100.00k0.0021%
HK$ 94.0k
Keith Frankel
Co-Chairman of Vitaquest International LLCno datageen gegevensgeen gegevens
Peter Peace Tulloch
Non-Executive Director22.6yrsHK$75.00k0.011%
HK$ 493.3k
Ying Choi Yu
Deputy Chairmanless than a yearHK$14.79m0.023%
HK$ 1.1m
Kai Cheong Kwan
Independent Non-executive Director9.7yrsHK$155.00kgeen gegevens
Donald Jeffrey Roberts
Independent Non-Executive Director4.3yrsHK$205.00kgeen gegevens
Joseph Paul Tighe
Independent Non-Executive Director5.4yrsHK$205.00kgeen gegevens

6.0yrs

Gemiddelde duur

70yo

Gemiddelde leeftijd

Ervaren bestuur: 775's board of directors are considered experienced (6 years average tenure).